Editorial Board

Dr Francesco Bertolini

European Institute of Oncology, Milan, Italy

Francesco Bertolini, MD, PhD is a clinician-scientist currently serving as the director of the laboratory of Hematology-Oncology at the IEO. Throughout his scientific career in Italy, at the Cardeza Foundation for Hematological Research at Thomas Jefferson University in Philadelphia and in the University of Amsterdam, Dr Bertolini has contributed to a variety of facets of cancer translational research in the angiogenesis and in the hematopoietic stem cell fields. Dr Bertolini’s research has generated the first cord blood stem cell bank in Europe, innovative preclinical models of neoplastic diseases, novel surrogate biomarkers for the prediction of anti-angiogenic drug efficacy in cancer patients and clinical trials where anti-angiogenic drugs are used in association with low-dose chemotherapy.